Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial (Q46300946)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial |
scientific article |
Statements
1 reference
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial (English)
1 reference
Robert M Califf
1 reference
Steven M Haffner
1 reference
Mitradev Boolell
1 reference
NAVIGATOR Study Group
1 reference
M Angelyn Bethel
1 reference
Anil Duggal
1 reference
Rury R Holman
1 reference
1 October 2008
1 reference
1 reference
156
1 reference
4
1 reference
623-632
1 reference
Identifiers
1 reference
1 reference